Molecular weight
372.5 Da
FDA-approved hair loss (Propecia 1mg) and BPH (Proscar 5mg). Commonly used alongside TRT to manage DHT-related side effects. Post-finasteride syndrome: persistent sexual dysfunction reported in subset of users — ongoing research.
Competitive inhibitor of 5-alpha reductase type II (and some type I). Blocks conversion of testosterone → dihydrotestosterone (DHT). Reduces serum DHT by ~70%, scalp DHT by ~60–70%. DHT is primary driver of androgenetic alopecia and benign prostatic hyperplasia. Relevant in peptide/TRT context: managing DHT elevation on testosterone therapy.
5-alpha reductase II inhibition; 70% DHT reduction; FDA-approved hair loss/BPH; TRT DHT management; post-finasteride syndrome research.
Research data is not a treatment plan. If you are considering Finasteride, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.
Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.Interactive tools for this compound:
Reconstitution calculator · Full deep dive · Peptide fundamentals